News Announcement

Vivanza Biosciences: Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended On 31St March 2026

Consideration of Audited Financial Results Standalone and Consolidated as per Indian Accounting Standards (Ind AS) along with the Audit Report of the Company for the Quarter and Year ended 31st March 2026 Took note of the Resignation of Mr. Hemant Amrish Parikh as a Non-Executive Director of the Company Took note of the Resignation of CS Chaitra Arora from the position of the CS and compliance officer Reconstitution of Committees of the Board with effect from 07th May 2026

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.